Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Icad Inc (ICAD)

Icad Inc (ICAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 109,235
  • Shares Outstanding, K 27,446
  • Annual Sales, $ 19,610 K
  • Annual Income, $ -5,620 K
  • EBIT $ -6 M
  • EBITDA $ -5 M
  • 60-Month Beta 1.35
  • Price/Sales 5.58
  • Price/Cash Flow N/A
  • Price/Book 3.56

Options Overview Details

View History
  • Implied Volatility 86.46% ( -20.38%)
  • Historical Volatility 136.56%
  • IV Percentile 1%
  • IV Rank 16.82%
  • IV High 323.55% on 07/26/24
  • IV Low 38.52% on 08/23/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 69
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 2,455
  • Open Int (30-Day) 3,357

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +666,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.00 +32.00%
on 04/21/25
4.01 -1.37%
on 05/16/25
+0.74 (+22.98%)
since 04/17/25
3-Month
1.55 +155.48%
on 04/07/25
4.01 -1.37%
on 05/16/25
+1.13 (+39.93%)
since 02/20/25
52-Week
1.18 +235.59%
on 07/05/24
4.01 -1.37%
on 05/16/25
+2.32 (+141.46%)
since 05/20/24

Most Recent Stories

More News
Icad: Q1 Earnings Snapshot

Icad: Q1 Earnings Snapshot

ICAD : 3.96 (-0.50%)
iCAD Reports Financial Results for First Quarter Ended March 31, 2025

ICAD : 3.96 (-0.50%)
Behind the FDA's AI Push: A Growing Class of Public Healthcare Innovators

/CNW/ -- USA News Group News Commentary – In a clear sign of growing confidence in artificial intelligence (AI) for healthcare, the U.S. Food and Drug...

MSFT : 458.17 (-0.15%)
AIDX.TO : 1.44 (-2.70%)
HWAIF : 1.0468 (-5.69%)
AVAI : 0.7700 (+18.46%)
RDNT : 60.16 (-0.82%)
ICAD : 3.96 (-0.50%)
Investors Are Watching Artificial Intelligence (AI) Reshape Diagnostics and Drug Discovery

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – The integration of artificial intelligence (AI) into healthcare is here to stay, and adoption is accelerating....

MSFT : 458.17 (-0.15%)
AVAI : 0.7700 (+18.46%)
LNTH : 76.83 (-1.81%)
RDNT : 60.16 (-0.82%)
ICAD : 3.96 (-0.50%)
Clinical AI Platforms Expand Globally Amid Regulatory and Market Tailwinds

/CNW/ -- Across the western healthcare landscape, artificial intelligence (AI) is being increasingly adopted to simplify authorizations and cut through layers...

AIDX.TO : 1.44 (-2.70%)
HWAIF : 1.0468 (-5.69%)
AVAI : 0.7700 (+18.46%)
PHG : 23.96 (+0.38%)
RDNT : 60.16 (-0.82%)
ICAD : 3.96 (-0.50%)
iCAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft’s Precision Imaging Network (PIN)

ICAD : 3.96 (-0.50%)
Is Healthcare the Next AI Gold Rush? Analysts Are Paying Close Attention

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – Artificial intelligence (AI) is still in the early stages of transforming healthcare—for both patients...

NVDA : 134.38 (-0.88%)
GOOG : 165.32 (-1.52%)
AVAI : 0.7700 (+18.46%)
ICAD : 3.96 (-0.50%)
CLOV : 3.69 (+2.50%)
RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer

RDNT : 60.16 (-0.82%)
ICAD : 3.96 (-0.50%)
iCAD Expands Executive Leadership with Appointment of Mark Koeniguer as Chief Commercial Officer

ICAD : 3.96 (-0.50%)
Icad: Q4 Earnings Snapshot

Icad: Q4 Earnings Snapshot

ICAD : 3.96 (-0.50%)

Business Summary

Icad, Inc. designs, engineers, develops and manufactures digital image scanners, densitometers, film digitizers and related software for applications in the graphic arts, medical imaging and life sciences markets. The Company sells its products throughout the world throughvarious distributors, resellers,...

See More

Key Turning Points

3rd Resistance Point 4.06
2nd Resistance Point 4.02
1st Resistance Point 3.99
Last Price 3.96
1st Support Level 3.92
2nd Support Level 3.88
3rd Support Level 3.85

See More

52-Week High 4.01
Last Price 3.96
Fibonacci 61.8% 2.93
Fibonacci 50% 2.60
Fibonacci 38.2% 2.26
52-Week Low 1.18

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
OSZAR »